Neuroepithelioma  >>  darleukin (L19IL2)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
darleukin (L19IL2) / Philogen
NCT01055522 / 2007-005737-11: Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma

Terminated
2
102
Europe
Arm 1: L19IL2 + Dacarbazine, Arm 3: Dacarbazine, DETICENE®, ARM 2: L19IL2 + Dacarbazine
Philogen S.p.A., Eudax S.r.l.
Metastatic Melanoma
02/13
02/14
NCT01253096 / 2009-014799-23: Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Completed
2
25
Europe
Intratumoral injections of L19IL2
Philogen S.p.A.
Malignant Melanoma
09/13
09/13
NCT02076633 / 2012-001991-13: Intratumoral Administration of L19IL2/L19TNF

Completed
2
21
Europe
L19IL2+L19TNF
Philogen S.p.A.
Malignant Melanoma, Skin
05/15
05/15

Download Options